184 related articles for article (PubMed ID: 31619590)
1. Muscarinic receptors promote pacemaker fate at the expense of secondary conduction system tissue in zebrafish.
Burczyk MS; Burkhalter MD; Tena TC; Grisanti LA; Kauk M; Matysik S; Donow C; Kustermann M; Rothe M; Cui Y; Raad F; Laue S; Moretti A; Zimmermann WH; Wess J; Kühl M; Hoffmann C; Tilley DG; Philipp M
JCI Insight; 2019 Oct; 4(20):. PubMed ID: 31619590
[TBL] [Abstract][Full Text] [Related]
2. [Role of ventricular M3 receptor in arrhythmia resulted from cerebral-cardiac syndrome].
Zhang GX; Pan GP; Sun LH; Zhang YL; Yang BF; Wang L
Yao Xue Xue Bao; 2008 Aug; 43(8):806-10. PubMed ID: 18956772
[TBL] [Abstract][Full Text] [Related]
3. Tolterodine--a new bladder-selective antimuscarinic agent.
Nilvebrant L; Andersson KE; Gillberg PG; Stahl M; Sparf B
Eur J Pharmacol; 1997 May; 327(2-3):195-207. PubMed ID: 9200560
[TBL] [Abstract][Full Text] [Related]
4. Zebrafish heart as a model to study the integrative autonomic control of pacemaker function.
Stoyek MR; Quinn TA; Croll RP; Smith FM
Am J Physiol Heart Circ Physiol; 2016 Sep; 311(3):H676-88. PubMed ID: 27342878
[TBL] [Abstract][Full Text] [Related]
5. Urothelial/lamina propria spontaneous activity and the role of M3 muscarinic receptors in mediating rate responses to stretch and carbachol.
Moro C; Uchiyama J; Chess-Williams R
Urology; 2011 Dec; 78(6):1442.e9-15. PubMed ID: 22001099
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the in vitro and in vivo profiles of tolterodine with those of subtype-selective muscarinic receptor antagonists.
Gillberg PG; Sundquist S; Nilvebrant L
Eur J Pharmacol; 1998 May; 349(2-3):285-92. PubMed ID: 9671109
[TBL] [Abstract][Full Text] [Related]
7. Muscarinic receptor subtypes involved in carbachol-induced contraction of mouse uterine smooth muscle.
Kitazawa T; Hirama R; Masunaga K; Nakamura T; Asakawa K; Cao J; Teraoka H; Unno T; Komori S; Yamada M; Wess J; Taneike T
Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun; 377(4-6):503-13. PubMed ID: 18071676
[TBL] [Abstract][Full Text] [Related]
8. Protective Effects of Antimuscarinics on the Bladder Remodeling After Bladder Outlet Obstruction.
Liu Q; Luo D; Yang T; Liao B; Li H; Wang KJ
Cell Physiol Biochem; 2017; 44(3):907-919. PubMed ID: 29176315
[TBL] [Abstract][Full Text] [Related]
9. Comparison of selective M3 and nonselective muscarinic receptor antagonists on gastrointestinal transit and bowel habits in humans.
Bharucha AE; Ravi K; Zinsmeister AR
Am J Physiol Gastrointest Liver Physiol; 2010 Jul; 299(1):G215-9. PubMed ID: 20395537
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of the cardiac conduction system.
van Eif VWW; Devalla HD; Boink GJJ; Christoffels VM
Nat Rev Cardiol; 2018 Oct; 15(10):617-630. PubMed ID: 29875439
[TBL] [Abstract][Full Text] [Related]
11. Regulation of bladder muscarinic receptor subtypes by experimental pathologies.
Ruggieri MR; Braverman AS
Auton Autacoid Pharmacol; 2006 Jul; 26(3):311-25. PubMed ID: 16879497
[TBL] [Abstract][Full Text] [Related]
12. Functional M3 cholinoreceptors are present in pacemaker and working myocardium of murine heart.
Abramochkin DV; Tapilina SV; Sukhova GS; Nikolsky EE; Nurullin LF
Pflugers Arch; 2012 Apr; 463(4):523-9. PubMed ID: 22350728
[TBL] [Abstract][Full Text] [Related]
13. Tolterodine Tartrate.
Ananchenko G; Novakovic J
Profiles Drug Subst Excip Relat Methodol; 2017; 42():339-403. PubMed ID: 28431780
[TBL] [Abstract][Full Text] [Related]
14. The Antimuscarinic Agent Tolterodine Regulates Bladder Extracellular Matrix in Partial Bladder Outlet Obstruction in Rats.
Yang TX; Luo DY; Lin YF; Liu Q; Cai X; Ai JZ; Li H; Shen H; Wang KJ
Cell Physiol Biochem; 2018; 46(1):36-45. PubMed ID: 29566360
[TBL] [Abstract][Full Text] [Related]
15. Functional selectivity of muscarinic receptor antagonists for inhibition of M3-mediated phosphoinositide responses in guinea pig urinary bladder and submandibular salivary gland.
Nelson CP; Gupta P; Napier CM; Nahorski SR; Challiss RA
J Pharmacol Exp Ther; 2004 Sep; 310(3):1255-65. PubMed ID: 15140916
[TBL] [Abstract][Full Text] [Related]
16. Activation state of the M3 muscarinic acetylcholine receptor modulates mammalian odorant receptor signaling.
Li YR; Matsunami H
Sci Signal; 2011 Jan; 4(155):ra1. PubMed ID: 21224444
[TBL] [Abstract][Full Text] [Related]
17. Cardiac resynchronization therapy restores sympathovagal balance in the failing heart by differential remodeling of cholinergic signaling.
DeMazumder D; Kass DA; O'Rourke B; Tomaselli GF
Circ Res; 2015 May; 116(10):1691-9. PubMed ID: 25733594
[TBL] [Abstract][Full Text] [Related]
18. Muscarinic agonist-mediated heterologous desensitization in isolated ileum requires activation of both muscarinic M2 and M3 receptors.
Griffin MT; Matsui M; Shehnaz D; Ansari KZ; Taketo MM; Manabe T; Ehlert FJ
J Pharmacol Exp Ther; 2004 Jan; 308(1):339-49. PubMed ID: 14563784
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of new cardioselective M2 muscarinic receptor antagonists.
Mandelli GR; Maiorana S; Terni P; Lamperti G; Colibretti ML; Imbimbo BP
Chem Pharm Bull (Tokyo); 2000 Nov; 48(11):1611-22. PubMed ID: 11086886
[TBL] [Abstract][Full Text] [Related]
20. Induction and patterning of the cardiac conduction system.
Pennisi DJ; Rentschler S; Gourdie RG; Fishman GI; Mikawa T
Int J Dev Biol; 2002 Sep; 46(6):765-75. PubMed ID: 12382942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
